Medicare Enrolled

Dr. Rhunjay Yu, M.D.

Student in an Organized Health Care Education/Training Program · Greenbrae, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
1000 S ELISEO DR STE 201, Greenbrae, CA 94904
4154614000
In practice since 2007 (18 years)
NPI: 1255527024 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yu

Dr. Rhunjay Yu is a student in an organized health care education/training program specialist in Greenbrae, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Yu performed 1,770 Medicare services across 1,470 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yu received a total of $69,383 from 35 pharmaceutical and/or device companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in CA $69,383 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,770
Medicare services
Top 11% in CA for student in an organized health care education/training program
1,470
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
492 $3 $21
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
457 $103 $565
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
364 $70 $386
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
128 $221 $1,258
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
128 $130 $830
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
84 $153 $759
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
24 $109 $618
Surgical removal of prostate and lymph nodes
This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope.
23 $951 $9,862
Suture suspension of urethra to control leakage using an endoscope
A surgical procedure that uses an endoscope to place sutures that suspend the urethra in order to control urinary leakage.
15 $316 $3,892
Bladder/urethra growth removal via endoscope, 0.5-2.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters.
14 $183 $1,176
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $85 $549
New patient office visit, complex (60-74 min) 14 $192 $1,085
Endoscopic removal of pelvic lymph nodes, bilateral
A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue.
13 $266 $4,478
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$69,383
Total received (2018-2024)
Avg $9,912/year across 7 years
Top 1% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
180
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,405 (32.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,958 (31.6%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$21,451 (30.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,569 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$723
2023
$1,045
2022
$4,543
2021
$17,317
2020
$19,077
2019
$18,796
2018
$7,882

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$149
Ferring Pharmaceuticals Inc.
$125
Sumitomo Pharma America, Inc.
$121
Medtronic, Inc.
$51
PFIZER INC.
$49
Becton, Dickinson and Company
$37
Janssen Biotech, Inc.
$33
IMMUNITYBIO, INC.
$31
C. R. Bard, Inc. & Subsidiaries
$30
ACCORD HEALTHCARE, INC.
$24
COLOPLAST CORP
$21
PROCEPT BioRobotics Corporation
$20
ABBVIE INC.
$16
BIOTISSUE HOLDINGS INC.
$14
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$34,762
Intuitive Surgical, Inc.
$21,018
Teleflex LLC
$10,456
Sumitomo Pharma America, Inc.
$505
Astellas Pharma US Inc
$369
Rochester Medical Corporation
$299
Janssen Biotech, Inc.
$239
Boston Scientific Corporation
$221
AbbVie, Inc.
$203
Telix Pharmaceuticals
$149
AbbVie Inc.
$135
Ferring Pharmaceuticals Inc.
$125
C. R. Bard, Inc. & Subsidiaries
$105
Myriad Genetic Laboratories, Inc.
$98
UroGen Pharma, Inc.
$70
PFIZER INC.
$68
Tolmar, Inc.
$59
ABBVIE INC.
$54
ROCHESTER MEDICAL CORPORATION
$51
Medtronic, Inc.
$51
Becton, Dickinson and Company
$37
PRESCIENT SURGICAL
$36
IMMUNITYBIO, INC.
$31
Smith+Nephew, Inc.
$29
ACCORD HEALTHCARE, INC.
$24
Myovant Sciences Inc.
$23
Blue Earth Diagnostics Limited
$22
Dendreon Pharmaceuticals LLC
$21
COLOPLAST CORP
$21
PROCEPT BioRobotics Corporation
$20
C. R. BARD, INC. & SUBSIDIARIES
$19
Allergan, Inc.
$17
Olympus America Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
BIOTISSUE HOLDINGS INC.
$14
Top 3 companies account for 95.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM SYSTEM · ARISTA AH FlexiTip · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CleanCision · Da Vinci Surgical System · ELIGARD · ERLEADA · GEMTESA · GENERAL BPH · ILLUCCIX · JELMYTO · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · ORGOVYX · PROLARIS · PROVENGE · Porges Coloplast · Prolaris · REZUM · Rezum Generator · SIGNIA · STRAVIX · SpaceOAR VUE System - 10mL · UROLIFT · UROLIFT 2 SYSTEM · UROLIFT SYSTEM · UroLift · UroLift ATC System · UroLift System · VESICARE · XTANDI · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (32%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for student in an organized health care education/training program in CA.

Looking for a student in an organized health care education/training program specialist in Greenbrae?
Compare student in an organized health care education/training programs in the Greenbrae area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
4,724
Per 100K population
1825.6
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yu is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with mixed engagement industry engagement in the top 1% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yu experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Yu performed 492 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yu receive payments from pharmaceutical companies?
Yes. Dr. Yu received a total of $69,383 from 35 companies across 180 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yu's costs compare to other student in an organized health care education/training programs in Greenbrae?
Dr. Yu's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →